Literature DB >> 12383916

Mechanism of increased maternal serum total activin a and inhibin a in preeclampsia.

Helayne M Silver1, Geralyn M Lambert-Messerlian, Fernando M Reis, Anna Maria Diblasio, Felice Petraglia, Jacob A Canick.   

Abstract

OBJECTIVE: To determine whether increased levels of maternal serum total activin A and inhibin A in preeclampsia are related to total blood volume, urinary clearance, or placental production. STUDY
DESIGN: Activin A and inhibin A levels were measured in preeclamptic subjects and matched normotensive gravidas. In a subset of preeclamptic subjects (n = 21) and controls (n = 30), we performed blood volume studies. In an overlapping subset of preeclamptic subjects (n = 56), creatinine clearance results were available. Placental tissue was obtained from six preeclamptics and matched normotensive gravida for analysis of activin A and inhibin A mRNA expression.
RESULTS: Maternal serum levels of inhibin A but not activin A were significantly negatively correlated with blood volume in preeclampsia (r(2) =.26, P =.017, and r(2) =.02, P =.44, respectively). Levels of both proteins were negatively correlated to creatinine clearance (r(2) =.29, P <.0001, and r(2) =.15, P =.003, respectively). Placental mRNA expression for both the alpha and betaA subunits was increased in preeclampsia (P =.038 and.049, respectively).
CONCLUSION: Although placental mRNA expression of the subunits for both analytes is increased in preeclampsia, the increased levels of activin A appear to be more specifically a reflection of increased placental production than do the increased levels of inhibin A.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12383916     DOI: 10.1016/s1071-5576(02)00165-x

Source DB:  PubMed          Journal:  J Soc Gynecol Investig        ISSN: 1071-5576


  7 in total

1.  Gene expression profiling of placentas affected by pre-eclampsia.

Authors:  Anne Mette Hoegh; Rehannah Borup; Finn Cilius Nielsen; Steen Sørensen; Thomas V F Hviid
Journal:  J Biomed Biotechnol       Date:  2010-03-03

Review 2.  Transforming growth factor β signaling in uterine development and function.

Authors:  Qinglei Li
Journal:  J Anim Sci Biotechnol       Date:  2014-11-14

3.  Dysregulated BMP2 in the Placenta May Contribute to Early-Onset Preeclampsia by Regulating Human Trophoblast Expression of Extracellular Matrix and Adhesion Molecules.

Authors:  Yuyin Yi; Hua Zhu; Christian Klausen; Hsun-Ming Chang; Amy M Inkster; Jefferson Terry; Peter C K Leung
Journal:  Front Cell Dev Biol       Date:  2021-12-14

4.  Sustained Elevated Circulating Activin A Impairs Global Longitudinal Strain in Pregnant Rats: A Potential Mechanism for Preeclampsia-Related Cardiac Dysfunction.

Authors:  Bhavisha A Bakrania; Ana C Palei; Umesh Bhattarai; Yingjie Chen; Joey P Granger; Sajid Shahul
Journal:  Cells       Date:  2022-02-21       Impact factor: 6.600

5.  Maternal circulating levels of activin A, inhibin A, sFlt-1 and endoglin at parturition in normal pregnancy and pre-eclampsia.

Authors:  Aparna Reddy; Sangeeta Suri; Ian L Sargent; Christopher W G Redman; Shanthi Muttukrishna
Journal:  PLoS One       Date:  2009-02-11       Impact factor: 3.240

Review 6.  The TGFβ Family in Human Placental Development at the Fetal-Maternal Interface.

Authors:  Susana M Chuva de Sousa Lopes; Marta S Alexdottir; Gudrun Valdimarsdottir
Journal:  Biomolecules       Date:  2020-03-13

7.  A study of the diagnostic value of Inhibin A Tests for occurrence of preeclampsia in pregnant women.

Authors:  Farzaneh Broumand; Shaker Salari Lak; Farhad Nemati; Atefeh Mazidi
Journal:  Electron Physician       Date:  2018-01-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.